Human IgG1, kappa - Isotype Control antibody,Abcam,AB288147

What is this antibody validated in? Human IgG1, kappa - Isotype Control Antibody (ab288147) is a human recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt). Other related products We have a range of other formats of antibody clone [MOPC-21] also available for your convenience: ab18443 , FITC - ab106163 , ab157226 , Alexa Fluor® 488 - ab234075 , Alexa Fluor® 647 - ab239459 , APC - ab239462 , ab239463 , ab239464 , ab242443 , ab288147, ab288148

Host

Human

Application

Flow Cyt, WB

Platform ID

BAB595403478

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameHuman IgG1, kappa - Isotype Control antibody
Cat. No.AB288147
HostHuman
IsotypeIgG1
ApplicationFlow Cyt, WB
ClonalityMonoclonal
Clone NumberMOPC-21
Concentration1 mg/mL Batch dependent concentration
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationPreservative: 0.02% Proclin 300 Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data The protein expressed by the IGHG4 gene is part of the constant region of immunoglobulin heavy chains. Immunoglobulins, or antibodies, are glycoproteins produced by B lymphocytes that can be membrane-bound or secreted. During humoral immunity's recognition phase, membrane-bound immunoglobulins act as receptors. When they bind a specific antigen, they trigger B lymphocytes to undergo clonal expansion and differentiate into plasma cells that secrete immunoglobulins. These secreted immunoglobulins then mediate the effector phase of humoral immunity to eliminate the bound antigens. Each immunoglobulin possesses two antigen binding sites, formed by the variable domains of a heavy chain and an associated light chain, allowing for high affinity binding to specific antigens. These variable domains undergo V-(D)-J rearrangement and may experience somatic hypermutations, facilitating affinity maturation after antigen exposure and selection. This supplementary information is collated from multiple sources and compiled automatically. See full target information IGHG4

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.